How I treat mucormycosis

Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species

(2011) M. Z. R. Gomes et al.   CLINICAL MICROBIOLOGY REVIEWS

Lessons from a Case of Oromandibular Mucormycosis Treated with Surgery and a Combination of Amphotericin B Lipid Formulation plus Caspofungin

(2010) Mario Ojeda-Uribe et al.   ACTA HAEMATOLOGICA

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

(2010) J. R. Wingard et al.   BLOOD

Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success

(2010) D P Kontoyiannis   BONE MARROW TRANSPLANTATION

Geoclimatic Factors and Invasive Aspergillosis after Allogeneic Hematopoietic Stem Cell Transplantation: New Perspectives for Patient Management?

(2010) Claudio Viscoli et al.   CLINICAL INFECTIOUS DISEASES

Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients

(2010) L. Pagano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice

(2010) Mingfu Liu et al.   JOURNAL OF CLINICAL INVESTIGATION

Molecular Detection and Identification of Zygomycetes Species from Paraffin-Embedded Tissues in a Murine Model of Disseminated Zygomycosis: a Collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) Evaluation

(2010) E. Dannaoui et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparative Pharmacodynamics of Amphotericin B Lipid Complex and Liposomal Amphotericin B in a Murine Model of Pulmonary Mucormycosis

(2009) R. E. Lewis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience

(2009) G. R. Thompson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fatal Rhizopus Pneumonia in Allogeneic Stem Cell Transplant Patients Despite Posaconazole Prophylaxis: Two Cases and Review of the Literature

(2009) Lazaros J. Lekakis et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Safe living after hematopoietic cell transplantation

(2009) D Yokoe et al.   BONE MARROW TRANSPLANTATION

Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation

(2009) V R Shannon et al.   BONE MARROW TRANSPLANTATION

Recent Advances in the Management of Mucormycosis: From Bench to Bedside

(2009) Brad Spellberg et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens

(2009) A. Marconi et al.   CLINICAL MICROBIOLOGY AND INFECTION

Spectrum of Zygomycete Species Identified in Clinically Significant Specimens in the United States

(2009) E. Alvarez et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A clinicopathological study of pulmonary mucormycosis in cancer patients: Extensive angioinvasion but limited inflammatory response

(2009) Ronen Ben-Ami et al.   JOURNAL OF INFECTION

Genomic Analysis of the Basal Lineage Fungus Rhizopus oryzae Reveals a Whole-Genome Duplication

(2009) Li-Jun Ma et al.   PLoS Genetics

Combination Echinocandin-Polyene Treatment of Murine Mucormycosis

(2008) A. S. Ibrahim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

When Primary Antifungal Therapy Fails

(2008) Marcio Nucci et al.   CLINICAL INFECTIOUS DISEASES

The Effect of Gastric Acid on the Absorption of Posaconazole

(2008) Rupali Jain et al.   CLINICAL INFECTIOUS DISEASES

Immunocompromised Hosts: Immunopharmacology of Modern Antifungals

(2008) R. Ben‐Ami et al.   CLINICAL INFECTIOUS DISEASES

Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis

(2008) Georgios Chamilos et al.   CLINICAL INFECTIOUS DISEASES

Reversed Halo Sign in Invasive Pulmonary Fungal Infections

(2008) Hisham Wahba et al.   CLINICAL INFECTIOUS DISEASES

Combination Polyene‐Caspofungin Treatment of Rhino‐Orbital‐Cerebral Mucormycosis

(2008) Caitlin Reed et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients: Biological Risk Factors for Infection According to Time after Transplantation

(2008) Carol Garcia‐Vidal et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

(2008) D. Neofytos et al.   CLINICAL INFECTIOUS DISEASES

Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment

(2008) Ashraf S Ibrahim et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Hyperbaric Oxygen: Applications in Infectious Disease

(2008) Colin G. Kaide et al.   EMERGENCY MEDICINE CLINICS OF NORTH AMERICA

Detection of a Molecular Biomarker for Zygomycetes by Quantitative PCR Assays of Plasma, Bronchoalveolar Lavage, and Lung Tissue in a Rabbit Model of Experimental Pulmonary Zygomycosis

(2008) M. Kasai et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections

(2008) Georgios Chamilos et al.   MEDICAL MYCOLOGY

Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up

(2008) Joseph J Kishel et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE